These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29848398)

  • 1. Pharmacologic therapy with flecainide for asymptomatic Wolff-Parkinson-White syndrome in an infant with severe left ventricular dyssynchrony.
    Suzuki S; Hokosaki T; Iwamoto M
    Cardiol Young; 2018 Jul; 28(7):970-973. PubMed ID: 29848398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I
    Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic cardiac resynchronization of a 1-year-old boy with severe left ventricular dysfunction.
    Paech C; Flosdorff P; Gebauer RA
    Pediatr Cardiol; 2012 Oct; 33(7):1213-5. PubMed ID: 22484822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of flecainide in the preventive treatment of tachycardia crisis of Wolff-Parkinson-White syndrome in 4 newborn infants].
    Lupoglazoff JM; Jacqz-Aigrain E; Denjoy I; Casasoprana A
    Arch Fr Pediatr; 1991 Nov; 48(9):627-9. PubMed ID: 1763931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of flecainide in the treatment of symptomatic children with Wolff-Parkinson-White syndrome.
    Núñez F; Ruiz-Granell R; Martínez-Costa C; Morell S; Brines J
    Pediatr Cardiol; 2010 Nov; 31(8):1162-5. PubMed ID: 20717658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects, efficacy and tolerance of class Ic antiarrhythmic agents in Wolff-Parkinson-White syndrome.
    Manolis AS; Salem DN; Estes NA
    Am J Cardiol; 1989 Mar; 63(11):746-50. PubMed ID: 2493734
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement in Dyssynchrony with Pharmacological Ablation of Right-Sided Accessory Pathway-Induced Cardiomyopathy in Infants.
    Sekine M; Masutani S; Imamura T; Iwamoto Y; Muraji S; Yoshiba S; Ishido H; Sumitomo N
    Int Heart J; 2019 Sep; 60(5):1201-1205. PubMed ID: 31484869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECGs in the ED.
    Tanel RE
    Pediatr Emerg Care; 2008 Nov; 24(11):803-4. PubMed ID: 19018229
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
    Brembilla-Perrot B; Admant P; Le Helloco A; Pernot C
    Eur Heart J; 1985 Dec; 6(12):1074-8. PubMed ID: 3830711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome.
    Ward DE; Jones S; Shinebourne EA
    Am J Cardiol; 1986 Apr; 57(10):787-90. PubMed ID: 3962866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome.
    Crijns HJ; den Heijer P; van Wijk LM; Lie KI
    Am Heart J; 1988 Jun; 115(6):1317-21. PubMed ID: 3132032
    [No Abstract]   [Full Text] [Related]  

  • 13. Flecainide improves cardiac synchronization in an early infant with Wolff-Parkinson-White syndrome with left ventricular dyssynchrony.
    Sumitomo NF; Fukushima N; Miura M
    J Cardiol Cases; 2020 Jul; 22(1):1-4. PubMed ID: 32636959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of left ventricular deformation and dyssynchrony on improvement of left ventricular ejection fraction following radiofrequency catheter ablation in Wolff-Parkinson-White syndrome: A comprehensive study by speckle tracking echocardiography.
    Nagai T; Hamabe A; Arakawa J; Tabata H; Nishioka T
    Echocardiography; 2017 Nov; 34(11):1610-1616. PubMed ID: 28929532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency treatment of Wolff-Parkinson-White syndrome.
    Brace S
    Emerg Nurse; 2011 Feb; 18(9):36-9. PubMed ID: 21384785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of the Wolf-Parkinson-White-syndrome by fetal magnetocardiography.
    Kähler C; Schleussner E; Schneider U; Seewald HJ
    BJOG; 2001 Mar; 108(3):335-6. PubMed ID: 11281480
    [No Abstract]   [Full Text] [Related]  

  • 17. The response of paediatric arrhythmias to intravenous and oral flecainide.
    Wren C; Campbell RW
    Br Heart J; 1987 Feb; 57(2):171-5. PubMed ID: 3101724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias.
    Wiseman MN; Elstob JE; Camm AJ; Nathan AW
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):767-75. PubMed ID: 1695357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined sotalol and flecainide given at low dosage in patients with the Wolff-Parkinson-White syndrome.
    Gössinger HD; Siostrzonek P; Mösslacher H
    Int J Cardiol; 1990 Mar; 26(3):380-2. PubMed ID: 2107150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
    Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.